Bhavik Enterprises Share Price & Earnings Call Analysis
- Market cap
- ₹297 Cr
- P/E
- 7.11
- ROE
- 10.29%
- PEG
- -1.73
- Price to sales
- 0.47
- Debt to equity
- 0.00
- 52W high / low
- ₹175 / ₹121
- Sales growth (5Y)
- 16.55%
- EBITDA margin
- 7.65%
- Net profit margin
- 2.16%
- Promoter holding
- 72.98%
- Sales (last year)
- ₹637 Cr
Incorporated in 2008, Bhavik Enterprises Limited is engaged in the trading of polymers primarily in Polyethylene (PE) and Polypropylene (PP).[1]
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Chemicals & Petrochemicals companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 0–2% | ₹234 Cr | 3.0 | |
| 2 | 40%+ | Flat | ₹3,888 Cr | 48.5 | |
| 3 | 40%+ | Flat | ₹3,514 Cr | 4.3 | |
| 4 | 40%+ | Flat | ₹180 Cr | 11.9 | |
| 5 | 40%+ | Flat | ₹138 Cr | 15.1 | |
| 6 | 20–40% | Up 2%+ | ₹1.70L Cr | 85.4 |
Sign up free to see every company in the sector ranking and track Bhavik Enterpris.
Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals rankingFinancials of Bhavik Enterpris
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Bhavik Enterpris
Quarterly Results
Quarter-by-quarter operating performance
Financials of Bhavik Enterpris
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 283 | 292 | 325 | 561 | 494 | 527 | 628 |
| Expenses + | 278 | 280 | 319 | 544 | 489 | 523 | 611 |
| Operating Profit | 5 | 12 | 6 | 17 | 5 | 4 | 17 |
| OPM % | 2% | 4% | 2% | 3% | 1% | 1% | 3% |
| Other Income + | 2 | 5 | 4 | 4 | 6 | 4 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 7 | 17 | 9 | 21 | 11 | 8 | 18 |
| Tax % | 28% | 27% | 26% | 26% | 26% | 26% | 26% |
| Net Profit + | 5 | 12 | 7 | 15 | 8 | 6 | 14 |
| EPS in Rs | 9.00 | 23.25 | 12.66 | 29.10 | 14.93 | 3.58 | 6.66 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Bhavik Enterpris
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 5 | 5 | 5 | 5 | 16 | 20 |
| Reserves | 45 | 57 | 64 | 79 | 87 | 82 | 145 |
| Borrowings + | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities + | 35 | 52 | 57 | 77 | 44 | 75 | 68 |
| Total Liabilities | 85 | 114 | 126 | 161 | 137 | 173 | 234 |
| Fixed Assets + | 1 | 1 | 1 | 2 | 1 | 1 | 1 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 3 | 0 | 0 | 8 |
| Other Assets + | 84 | 112 | 125 | 156 | 135 | 172 | 225 |
| Total Assets | 85 | 114 | 126 | 161 | 137 | 173 | 234 |
Financials of Bhavik Enterpris
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 5 | 26 | 1 | 14 | -3 | -33 | |
| Cash from Investing Activity + | 1 | 1 | 2 | -1 | 3 | -2 | |
| Cash from Financing Activity + | -0 | -0 | 0 | -0 | -0 | 0 | |
| Net Cash Flow | 6 | 28 | 2 | 12 | -0 | -34 | |
| Free Cash Flow | 5 | 26 | 0 | 10 | -3 | -37 | |
| CFO/OP | 154% | 257% | 52% | 111% | -20% | -786% |
Financials of Bhavik Enterpris
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 43 | 36 | 41 | 27 | 26 | 42 | 31 |
| Inventory Days | 31 | 39 | 31 | 31 | 22 | 49 | 38 |
| Days Payable | 43 | 61 | 57 | 49 | 32 | 54 | 40 |
| Cash Conversion Cycle | 31 | 14 | 15 | 9 | 16 | 36 | 29 |
| Working Capital Days | 28 | 7 | 5 | 6 | 17 | 41 | 32 |
| ROCE % | 30% | 14% | 28% | 12% | 8% | 14% |
Continue your research
Others in Chemicals & Petrochemicals this season
- J.G.Chemicals (Q2 FY27)
Q2 FY27 Revenue from Operations: ₹3,610 million, up 63.9% YoY (₹2,203 million in Q2 FY26) (Page 23) . Key investor presentation takeaways from J.G.Chemicals Ltd
- Lords Chloro (Q2 FY27)
115.40 Crore, up 17.34% YoY from Rs. Key investor presentation takeaways from Lords Chloro Alkali Ltd's Q2 FY27 investor presentation — and how it ranks against
- Camlin Fine (Q2 FY27)
Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27
- Gujarat Fluoroch (Q2 FY27)
Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv